![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, August 06, 2023 10:56:39 AM
Yes, the DOT finalized rule sets a 4 nanogram per milliliter screening test cutoff for THC, which it said in its earlier notice “would detect use of marijuana while eliminating possibilities of positive tests resulting from passive exposure.” I'm certain that Lifeloc is concentrating their efforts to improve the accuracy of their drug testing platform to meet the criteria set by the DOT.
A very important thing to remember here, is that prior to June 1, there was no set cutoff point for the amount of THC to be considered "over the limit." The DOT has now set this limit, which now creates a set point for testing, much like alcohol is set at .04 for commercial drivers, and .08 for most other drivers in most states. The argument that "there is no predetermined amount of THC in your system to be considered over the limit," is no longer valid. The DOT has set it at 4ng/ml.
For Lifeloc to achieve what they have in their R&D of this new product, without diluting shareholder value, and maintaining profitability, is an amazing feat in itself. Most small, OTC companies have no real revenue streams, and rely on their operations being completely funded by sale of their common stock. This is why there is such aversion from large fund investing in OTC companies. Lifeloc stands out of the crowd here, and, in my opinion, is being largely overlooked by investors. This is why buying now, when there is little to no interest in shares of LCTC stock, makes sense.
The management at Lifeloc seem to be confident in the product, and are starting to comment on the progress they are making - including current validation testing being performed on human samples. Still flying under the radar, but not for long....
Recent LCTC News
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/31/2024 07:22:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:30:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:15:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:14:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:46:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 02:57:07 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/23/2023 02:57:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 09:11:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:21:40 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM